Magdi Yaqoob

Magdi Yaqoob is a Professor of Nephrology at Queen Mary University of London (QMUL) and Academic Director of Renal Medicine and Transplantation at Barts Health NHS Trust. His research focuses on cardiovascular complications of uraemia, renal anaemia, chronic kidney disease progression, and transplant outcomes. He graduated from Dow Medical College, Karachi, and trained in the UK, gaining an MD from Liverpool University and a NIH fellowship under Prof Robert Schrier in Colorado. He has been recognized with awards including Best European Young Investigator (1992) and Trainee Investigator of the Year (USA, 1994).

• Roles: Joint Head of Department at William Harvey Research Institute, Academic Director of Renal Medicine
• Research Themes: Kidney fibrosis, autophagy in uraemia, EPO resistance, transplant immunology
• Awards: Multiple international recognitions for early-career contributions to nephrology

Dr. Yaqoob’s work bridges basic science and clinical practice, with recent studies exploring gut dysbiosis in kidney disease, therapeutic repositioning strategies (e.g., artesunate), and translational approaches to CKD management. His team investigates novel biomarkers and drug targets for conditions like ischaemia-reperfusion injury and renal transplant outcomes.

Key collaborations include the NIHR-funded Barts-BRU initiative and partnerships with institutions in the Netherlands, Italy, and the USA. His translational research emphasizes improving patient outcomes through precision medicine and innovative therapies targeting uremic complications.